Catheter-associated bacterial flora in patients with benign prostatic hyperplasia: shift in antimicrobial susceptibility pattern.
Bartosz A DybowskiPiotr ZapałaEwa Bres-NiewadaŁukasz ZapałaNina Miązek-ZapałaSławomir PoletajewGrażyna MłynarczykPiotr RadziszewskiPublished in: BMC infectious diseases (2018)
Substantial rise in the incidence of Gram-positive species and fluctuations in antimicrobial susceptibility patterns were found. Empirical therapy of genitourinary infection in catheterized men with BPH should now involve antimicrobial agents effective both to Enterococci and Enterobacteriaceae. Periodic monitoring and publishing data on antimicrobial susceptibility for this population is necessary.
Keyphrases
- benign prostatic hyperplasia
- lower urinary tract symptoms
- multidrug resistant
- gram negative
- pseudomonas aeruginosa
- staphylococcus aureus
- risk factors
- electronic health record
- big data
- middle aged
- urinary tract infection
- escherichia coli
- genetic diversity
- cystic fibrosis
- mesenchymal stem cells
- bone marrow
- artificial intelligence